Skip to main navigation Skip to search Skip to main content

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

  • Jenny Low
  • , Yan'an Hou
  • , Angelia Chow
  • , Shiqin Howe
  • , Chan Wing Ki
  • , Tan Kah Hin
  • , Jasmine S Chung
  • , Benjamin P Cherng
  • , David C Lye
  • , Paul A Tambayah
  • , Lee Ching Ng
  • , Cynthia Sung
  • , John Connolly
  • , Martin L Hibberd
  • , Yee Sin Leo
  • , Eeng Eong Ooi
  • , Subhash G Vasudevan
  • , Yin Bun Cheung
  • , Wijaya Limin
  • , Yuan Wei
  • Abhay P Rathore, Satoru Watanabe, Boon Hian Tan, Liying Toh, Lian Chua

    Research output: Contribution to journalArticleScientificpeer-review

    226 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)706-715
    JournalThe Lancet Infectious Diseases
    Volume14
    Issue number8
    DOIs
    Publication statusPublished - 2014
    Publication typeA1 Journal article-refereed

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Publication forum classification

    • Publication forum level 3

    Cite this